Terms: = Lymphoma AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD
129 results:
1. Contrast-enhanced CT-based radiomics differentiate anterior mediastinum lymphoma from thymoma without myasthenia gravis and calcification.
Huang X; Wang X; Liu Y; Wang Z; Li S; Kuang P
Clin Radiol; 2024 Apr; 79(4):e500-e510. PubMed ID: 38242804
[TBL] [Abstract] [Full Text] [Related]
2. Immunotyping of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma.
Qi F; Wei Y; Wu M; Sun Y; Xie Y; Lin N; Liu W; Wang W; Song Y; Zhu J
Ann Hematol; 2024 May; 103(5):1643-1653. PubMed ID: 38191717
[TBL] [Abstract] [Full Text] [Related]
3. Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial.
Mori T; Osumi T; Kada A; Ohki K; Koga Y; Fukano R; Fujita N; Mitsui T; Mori T; Saito AM; Nakazawa A; Kobayashi R; Sekimizu M
Eur J Haematol; 2024 Apr; 112(4):585-593. PubMed ID: 38112205
[TBL] [Abstract] [Full Text] [Related]
4. CXCR4-directed PET/CT with [
Dreher N; Hahner S; Fuß CT; Schlötelburg W; Hartrampf PE; Serfling SE; Schirbel A; Samnick S; Higuchi T; Weich A; Lapa C; Rosenwald A; Buck AK; Kircher S; Werner RA
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1383-1394. PubMed ID: 38082196
[TBL] [Abstract] [Full Text] [Related]
5. A novel NET-related gene signature for predicting DLBCL prognosis.
Shi H; Pan Y; Xiang G; Wang M; Huang Y; He L; Wang J; Fang Q; Li L; Liu Z
J Transl Med; 2023 Sep; 21(1):630. PubMed ID: 37716978
[TBL] [Abstract] [Full Text] [Related]
6. Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia.
Hoshitsuki K; Zhou Y; Miller AM; Choi JK; Swanson HD; Bhakta NH; Jeha S; Karol SE; Ribeiro RC; Rubnitz JE; Mullighan CG; Cheng C; Yang JJ; Relling MV; Pui CH; Inaba H
Leukemia; 2023 Sep; 37(9):1782-1791. PubMed ID: 37543655
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study.
Jang H; Yu SJ; Lee HG; Kim TM; Lee YB; Cho EJ; Lee JH; Yoon JH; Kim YJ
J Korean Med Sci; 2023 Jul; 38(28):e216. PubMed ID: 37463687
[TBL] [Abstract] [Full Text] [Related]
8. Health resource utilization and costs of care for adult patients with relapsed or refractory mantle cell lymphoma in the United States: a retrospective claims analysis.
Ito D; Feng C; Fu C; Kim C; Wu J; Epstein J; Snider JT; DuVall AS
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):773-787. PubMed ID: 37278284
[TBL] [Abstract] [Full Text] [Related]
9. Incidence and Mortality Rates for Childhood Acute Lymphoblastic Leukemia in Puerto Rican Hispanics, 2012-2016.
Montes-Rodríguez IM; Soto-Salgado M; Torres-Cintrón CR; Tomassini-Fernandini JC; Suárez E; Clavell LA; Cadilla CL
Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1030-1037. PubMed ID: 37222662
[TBL] [Abstract] [Full Text] [Related]
10. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract] [Full Text] [Related]
11. Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia.
Patel PA; DeGroote NP; Jackson K; Cash T; Castellino SM; Jaggi P; Esbenshade AJ; Miller TP
Cancer; 2022 Dec; 128(23):4129-4138. PubMed ID: 36238979
[TBL] [Abstract] [Full Text] [Related]
12. Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trial.
Pagel JM; Soumerai JD; Reddy N; Jagadeesh D; Stathis A; Asch A; Salman H; Kenkre VP; Iasonos A; Llorin-Sangalang J; Li J; Zelenetz AD
Lancet Oncol; 2022 Aug; 23(8):1021-1030. PubMed ID: 35835137
[TBL] [Abstract] [Full Text] [Related]
13. Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway.
Ma Y; Li Y; Huang M; Meng Y
J Chemother; 2023 May; 35(3):240-249. PubMed ID: 35666085
[TBL] [Abstract] [Full Text] [Related]
14. Economic Cost and Sustainability of Oral Therapies in Precision Oncology.
Desai AP; Scheckel CJ; Soderberg LC; Jensen CJ; Orme JJ; Tella SH; Kommalapati A; Pritchett JC; Khera N; Mahipal A; Go RS;
JCO Oncol Pract; 2022 Aug; 18(8):e1247-e1254. PubMed ID: 35617640
[TBL] [Abstract] [Full Text] [Related]
15. CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies.
Bruno S; Ghelli Luserna di Rorà A; Napolitano R; Soverini S; Martinelli G; Simonetti G
J Exp Clin Cancer Res; 2022 Apr; 41(1):159. PubMed ID: 35490245
[TBL] [Abstract] [Full Text] [Related]
16. Validation of Convolutional Neural Networks for Fast Determination of Whole-Body Metabolic Tumor Burden in Pediatric lymphoma.
Etchebehere E; Andrade R; Camacho M; Lima M; Brink A; Cerci J; Nadel H; Bal C; Rangarajan V; Pfluger T; Kagna O; Alonso O; Begum FK; Mir KB; Magboo VP; Menezes LJ; Paez D; Pascual TN
J Nucl Med Technol; 2022 Sep; 50(3):256-262. PubMed ID: 35440476
[No Abstract] [Full Text] [Related]
17. sIL-2R: A Novel Diagnostic Biomarker for Primary Adrenal lymphoma.
Yu K; Xie W; Zhao L; Wang H; Ren Y; Zheng C; Chen X; Su Z; Tang Y; Zhou F; Tian H; Zhu Y; Chen T
J Clin Endocrinol Metab; 2022 May; 107(6):e2284-e2290. PubMed ID: 35254444
[TBL] [Abstract] [Full Text] [Related]
18. Trends in Prices of Drugs Used to Treat Metastatic Non-Small Cell Lung Cancer in the US From 2015 to 2020.
Desai A; Scheckel C; Jensen CJ; Orme J; Williams C; Shah N; Leventakos K; Adjei AA
JAMA Netw Open; 2022 Jan; 5(1):e2144923. PubMed ID: 35076701
[TBL] [Abstract] [Full Text] [Related]
19. Adiponectin and Its Effects on Acute Leukemia Cells: An Experimental and Bioinformatics Approach.
Tsartsalis AN; Tagka A; Kotoulas A; Mirkopoulou D; Geronikolou SA; G L
Adv Exp Med Biol; 2021; 1338():117-127. PubMed ID: 34973016
[TBL] [Abstract] [Full Text] [Related]
20. Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study.
Rutherford SC; Abramson JS; Bartlett NL; Barta SK; Khan N; Joyce R; Maddocks K; Ali-Shaw T; Senese S; Yuan Y; Westin J; Leonard JP
Lancet Haematol; 2021 Nov; 8(11):e818-e827. PubMed ID: 34634256
[TBL] [Abstract] [Full Text] [Related]
[Next]
